Literature DB >> 36253429

Molecular landscape of immune pressure and escape in aplastic anemia.

Simona Pagliuca1,2, Carmelo Gurnari1,3, Colin Hercus4, Sébastien Hergalant5, Niroshan Nadarajah6, Adam Wahida6, Laila Terkawi1, Minako Mori1, Weiyin Zhou7,8, Valeria Visconte1, Stephen Spellman9, Shahinaz M Gadalla7, Caiying Zhu10, Ping Zhu10, Torsten Haferlach6, Jaroslaw P Maciejewski11.   

Abstract

Idiopathic aplastic anemia (IAA) pathophysiology is dominated by autoreactivity of human leukocyte antigen (HLA)-restricted T-cells against antigens presented by hematopoietic stem and progenitor cells (HSPCs). Expansion of PIGA and HLA class I mutant HSPCs have been linked to immune evasion from T-cell mediated pressures. We hypothesized that in analogy with antitumor immunity, the pathophysiological cascade of immune escape in IAA is initiated by immunoediting pressures and culminates with mechanisms of clonal evolution characterized by hits in immune recognition and response genes. To that end, we studied the genetic and transcriptomic make-up of the antigen presentation complexes in a large cohort of patients with IAA and paroxysmal nocturnal hemoglobinuria (PNH) by using single-cell RNA, high throughput DNA sequencing and single nucleotide polymorphism (SNP)-array platforms. At disease onset, HSPCs displayed activation of selected HLA class I and II-restricted mechanisms, without extensive inhibition of immune checkpoint apparatus. Using a newly implemented bioinformatic framework we found that not only class I but also class II genes were often impaired by acquisition of genetic aberrations. We also demonstrated the presence of novel somatic alterations in immune genes possibly contributing to the evasion from the autoimmune T-cells. In contrast, these hits were absent in myeloid neoplasia. These aberrations were not mutually exclusive with PNH and did not correlate with the accumulation of myeloid-driver hits. Our findings shed light on the mechanisms of immune activation and escape in IAA and define alternative modes of clonal hematopoiesis.
© 2022. The Author(s), under exclusive licence to Springer Nature Limited.

Entities:  

Year:  2022        PMID: 36253429     DOI: 10.1038/s41375-022-01723-w

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   12.883


  46 in total

1.  Functional characterization of CD4+ T cells in aplastic anemia.

Authors:  Shahram Kordasti; Judith Marsh; Sufyan Al-Khan; Jie Jiang; Alexander Smith; Azim Mohamedali; Pilar Perez Abellan; Caroline Veen; Benedetta Costantini; Austin G Kulasekararaj; Nana Benson-Quarm; Thomas Seidl; Syed A Mian; Farzin Farzaneh; Ghulam J Mufti
Journal:  Blood       Date:  2011-12-02       Impact factor: 22.113

Review 2.  Current concepts in the pathophysiology and treatment of aplastic anemia.

Authors:  Neal S Young
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2013

3.  Th17 immune responses contribute to the pathophysiology of aplastic anemia.

Authors:  Regis Peffault de Latour; Valeria Visconte; Tomoiku Takaku; Colin Wu; Andrew J Erie; Annahita K Sarcon; Marie J Desierto; Phillip Scheinberg; Keyvan Keyvanfar; Olga Nunez; Jichun Chen; Neal S Young
Journal:  Blood       Date:  2010-08-23       Impact factor: 22.113

4.  Changes in T-cell receptor VB repertoire in aplastic anemia: effects of different immunosuppressive regimens.

Authors:  Hoon Kook; Antonio M Risitano; Weihua Zeng; Marcin Wlodarski; Craig Lottemann; Ryotaro Nakamura; John Barrett; Neal S Young; Jaroslaw P Maciejewski
Journal:  Blood       Date:  2002-05-15       Impact factor: 22.113

5.  Somatic Mutations and Clonal Hematopoiesis in Aplastic Anemia.

Authors:  Tetsuichi Yoshizato; Bogdan Dumitriu; Kohei Hosokawa; Hideki Makishima; Kenichi Yoshida; Danielle Townsley; Aiko Sato-Otsubo; Yusuke Sato; Delong Liu; Hiromichi Suzuki; Colin O Wu; Yuichi Shiraishi; Michael J Clemente; Keisuke Kataoka; Yusuke Shiozawa; Yusuke Okuno; Kenichi Chiba; Hiroko Tanaka; Yasunobu Nagata; Takamasa Katagiri; Ayana Kon; Masashi Sanada; Phillip Scheinberg; Satoru Miyano; Jaroslaw P Maciejewski; Shinji Nakao; Neal S Young; Seishi Ogawa
Journal:  N Engl J Med       Date:  2015-07-02       Impact factor: 91.245

Review 6.  Aplastic anemia: Pathophysiology.

Authors:  Valentina Giudice; Carmine Selleri
Journal:  Semin Hematol       Date:  2022-01-05       Impact factor: 3.851

Review 7.  Immunologic effects on the haematopoietic stem cell in marrow failure.

Authors:  Bhavisha A Patel; Valentina Giudice; Neal S Young
Journal:  Best Pract Res Clin Haematol       Date:  2021-06-03       Impact factor: 3.020

8.  Intracellular interferon-gamma in circulating and marrow T cells detected by flow cytometry and the response to immunosuppressive therapy in patients with aplastic anemia.

Authors:  Elaine Sloand; Sonnie Kim; Jaroslaw P Maciejewski; John Tisdale; Dean Follmann; Neal S Young
Journal:  Blood       Date:  2002-08-15       Impact factor: 22.113

9.  Oligoclonal and polyclonal CD4 and CD8 lymphocytes in aplastic anemia and paroxysmal nocturnal hemoglobinuria measured by V beta CDR3 spectratyping and flow cytometry.

Authors:  Antonio M Risitano; Hoon Kook; Weihua Zeng; Guibin Chen; Neal S Young; Jaroslaw P Maciejewski
Journal:  Blood       Date:  2002-07-01       Impact factor: 22.113

10.  Deep sequencing and flow cytometric characterization of expanded effector memory CD8+CD57+ T cells frequently reveals T-cell receptor Vβ oligoclonality and CDR3 homology in acquired aplastic anemia.

Authors:  Valentina Giudice; Xingmin Feng; Zenghua Lin; Wei Hu; Fanmao Zhang; Wangmin Qiao; Maria Del Pilar Fernandez Ibanez; Olga Rios; Neal S Young
Journal:  Haematologica       Date:  2018-02-01       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.